Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2

This publication has 39 references indexed in Scilit:

• Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
  JAMA, 1999
• Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis
  JAMA, 1999
• Experimental models used to investigate the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 by non-steroidal anti-inflammatory drugs
  Inflammation Research, 1998
• Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings*
  Clinical Pharmacology & Therapeutics, 1998
• Selective inhibition of cyclooxygenase-1 and -2 using intact insect cell assays
  Biochemical Pharmacology, 1996
• Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells
  Biochemical Pharmacology, 1996
• A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors
  Inflammation Research, 1996
• Meloxican: Influence on arachidonic acid metabolism: Part 1. In vitro findings
  Biochemical Pharmacology, 1996
• Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1
  European Journal of Pharmacology, 1995
• Purification and Characterization of Recombinant Human Cyclooxygenase-2
  Archives of Biochemistry and Biophysics, 1994